Andrew Dunlop
St Bartholomew's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrew Dunlop.
The Lancet | 1975
A. Richens; Andrew Dunlop
Steady-state serum-phenytoin levels were measured in five patients whose phenytoin dosage was changed three or more times for therapeutic purposes. Data from four of these patients and from fifteen others have been used to construct a nomogram which permits the clinician, given a single, accurate, steady-state phenytoin level, to adjust the dosage to achieve the desirable therapeutic concentration of 60 or 80 mumol per litre (15 or 20 mug. per ml.).
Therapeutic Drug Monitoring | 1979
B. Rambeck; H.-E. Boenigk; Andrew Dunlop; P. W. Mullen; Jane Wadsworth; Alan Richens
The nomogram devised by Richens and Dunlop for predicting phenytoin dose has been tested in 127 residential epileptic patients, and the data obtained were used to prepare a revised version of the nomogram. In a further 78 patients, this new version was found to be superior to the original. The mean Km value was found to be 23.8 μmoles/liter. Km was independent of age and body surface area, but Dmax correlated positively with the latter two variables.
The Lancet | 1975
Lars H. Lund; Gunnar Alván; A. Richens; Andrew Dunlop
The Lancet | 1878
Andrew Dunlop
The Lancet | 1976
A. Richens; Andrew Dunlop; Suhail Ahmad; John Laidlaw
The Lancet | 1871
Andrew Dunlop
The Lancet | 1911
Alexander Morison; Andrew Dunlop
The Lancet | 1882
Andrew Dunlop
Therapeutic Drug Monitoring | 1979
Bernhard Rambeck; H.-E. Boenigk; Andrew Dunlop; Paul Mullen; Jane Wadsworth; Alan Richens
The Lancet | 1909
Andrew Dunlop
